• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高预处理血小板与淋巴细胞比值与男性喉和下咽鳞状细胞癌的不良预后相关。

High pretreatment platelet-to-lymphocyte ratio is related to poor prognosis in the squamous cell carcinoma of the larynx and hypopharynx in male patients.

机构信息

Department of Otolaryngology Head and Neck Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Jiangsu Provincial Key Medical Discipline (Laboratory), Nanjing, China.

Research Institute of Otolaryngology, Nanjing, China.

出版信息

Acta Otolaryngol. 2021 Apr;141(4):419-423. doi: 10.1080/00016489.2020.1869305. Epub 2021 Jan 29.

DOI:10.1080/00016489.2020.1869305
PMID:33508996
Abstract

BACKGROUND

There were heterogeneous or even conflicting data regarding the ability of platelet-to-lymphocyte ratio (PLR) for predicting the prognosis of laryngeal/hypopharyngeal squamous cell carcinoma (LHSCC). The discrepancies were found to be largely due to the cutoff value of PLR.

AIMS

The aims of this study were to rationally select an optimal PLR cutoff value and to analyze the relationship between pretreatment PLR and the prognosis.

METHODS

A total of 180 male patients were eligible for this retrospective study. We included another 180 healthy male individuals as controls. The relationship between PLR and age in patients and the controls was determined. The optimal cutoff values of PLR were identified. PLR value was then dichotomized into two categories, and the relationship between PLR and the clinicopathologic parameters were calculated. Kaplan-Meier curves were used to evaluate the overall survival (OS), and the association between PLR and the OS was analyzed.

RESULTS

The linear regression analysis showed a positive correlation between age and PLR in the control group, but not the patients. The optimal cutoff value of PLR was 112.5. The high PLR value group of patients exhibited significantly decreased OS. PLR was related to prognosis, as revealed by the univariate Cox regression.

CONCLUSION

Patients with LHSCC have abnormal high PLR, and a high pretreatment PLR portends adverse survival.

摘要

背景

血小板与淋巴细胞比值(PLR)预测喉/下咽鳞状细胞癌(LHSCC)预后的能力存在异质性,甚至相互矛盾,差异主要归因于 PLR 的截断值。

目的

本研究旨在合理选择最佳 PLR 截断值,并分析治疗前 PLR 与预后之间的关系。

方法

共纳入 180 名符合条件的男性患者作为研究对象,同时纳入 180 名健康男性作为对照组。分析患者和对照组中 PLR 与年龄的关系,确定最佳 PLR 截断值。将 PLR 值分为两类,计算 PLR 与临床病理参数之间的关系。采用 Kaplan-Meier 曲线评估总生存率(OS),分析 PLR 与 OS 的关系。

结果

线性回归分析显示,对照组中年龄与 PLR 呈正相关,但患者中无此相关性。PLR 的最佳截断值为 112.5。高 PLR 值组患者的 OS 明显降低。单因素 Cox 回归分析显示 PLR 与预后相关。

结论

LHSCC 患者的 PLR 异常升高,治疗前 PLR 升高预示着不良预后。

相似文献

1
High pretreatment platelet-to-lymphocyte ratio is related to poor prognosis in the squamous cell carcinoma of the larynx and hypopharynx in male patients.高预处理血小板与淋巴细胞比值与男性喉和下咽鳞状细胞癌的不良预后相关。
Acta Otolaryngol. 2021 Apr;141(4):419-423. doi: 10.1080/00016489.2020.1869305. Epub 2021 Jan 29.
2
Presurgical platelet-lymphocyte ratio for prognosis in advanced hypopharyngeal squamous cell carcinoma in individuals undergoing radical resection.根治性切除术治疗中晚期下咽鳞癌患者术前血小板-淋巴细胞比值与预后的关系
Acta Otolaryngol. 2021 May;141(5):537-543. doi: 10.1080/00016489.2021.1891456. Epub 2021 Apr 19.
3
The Prognostic Value of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio in Patients With Laryngeal Squamous Cell Carcinoma.术前血浆纤维蛋白原和中性粒细胞与淋巴细胞比值对喉鳞状细胞癌患者的预后价值。
Ear Nose Throat J. 2021 Dec;100(10):731-736. doi: 10.1177/0145561320920746. Epub 2020 May 7.
4
Prognostic Analysis of Preoperative Inflammatory Biomarkers in Patients With Laryngeal Squamous Cell Carcinoma.术前炎症生物标志物对喉鳞状细胞癌患者预后的分析。
Ear Nose Throat J. 2020 Jul;99(6):371-378. doi: 10.1177/0145561319876910. Epub 2019 Sep 30.
5
Platelet-to-lymphocyte ratio predicts long-term survival in laryngeal cancer.血小板与淋巴细胞比值可预测喉癌患者的长期生存情况。
Eur Arch Otorhinolaryngol. 2018 Feb;275(2):553-559. doi: 10.1007/s00405-017-4849-4. Epub 2017 Dec 23.
6
Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.治疗前淋巴细胞与单核细胞比值作为头颈癌的独立预后因素
Head Neck. 2017 Feb;39(2):247-253. doi: 10.1002/hed.24576. Epub 2016 Sep 12.
7
Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx.喉癌或下咽癌患者围手术期血浆中mRNA水平的潜在临床意义。
Head Neck. 2017 Apr;39(4):647-655. doi: 10.1002/hed.24638. Epub 2017 Feb 22.
8
The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma.治疗前中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及红细胞分布宽度可预测喉癌患者的预后。
Eur Arch Otorhinolaryngol. 2017 Jan;274(1):535-542. doi: 10.1007/s00405-016-4250-8. Epub 2016 Aug 12.
9
Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.术前中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值对胆囊癌患者的预后意义
Clin Transl Oncol. 2015 Oct;17(10):810-8. doi: 10.1007/s12094-015-1310-2. Epub 2015 Jun 16.
10
Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.术前炎症标志物对行手术切除的喉鳞状细胞癌患者的生存和预后分析。
BMC Cancer. 2018 Aug 13;18(1):816. doi: 10.1186/s12885-018-4730-x.

引用本文的文献

1
Editorial for "a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators".关于“基于血液指标的PD-1抑制剂治疗的ESCC患者irAEs预测模型”的社论
Future Sci OA. 2025 Dec;11(1):2527486. doi: 10.1080/20565623.2025.2527486. Epub 2025 Jul 1.
2
Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus status.人乳头瘤病毒状态对头部和颈部鳞状细胞癌患者生存结局的全身炎症生物标志物的差异预后关联
Neoplasia. 2025 Aug;66:101178. doi: 10.1016/j.neo.2025.101178. Epub 2025 May 16.
3
Prognostic Significance of Pre-Treatment Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Head and Neck Malignancies.
治疗前中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在头颈部恶性肿瘤中的预后意义
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):567-574. doi: 10.1007/s12070-023-04213-2. Epub 2023 Sep 16.
4
Risk of head and neck cancer in relation to blood inflammatory biomarkers in the Swedish AMORIS cohort.与瑞典 AMORIS 队列中血液炎症生物标志物相关的头颈部癌症风险。
Front Immunol. 2023 Oct 9;14:1265406. doi: 10.3389/fimmu.2023.1265406. eCollection 2023.
5
Role and research progress of hematological markers in laryngeal squamous cell carcinoma.血液学标志物在喉鳞状细胞癌中的作用及研究进展。
Diagn Pathol. 2023 Apr 20;18(1):50. doi: 10.1186/s13000-023-01335-7.